N
NSRX
Nasus Pharma Ltd.
4.050
-0.050-1.22%Closed19:30 08/26 EDT
OPEN/PREV CLOSE4.090/4.100
TODAY RANGE3.869-4.090
VOL4.46K
MARKET CAP47.43M
52 WEEK RANGE1.980-9.50
AVG VOL (3M)25.93K
% TURNOVER0.04%
TURNOVER--
P/E (TTM)-7.5461
% RANGE4.42%
EPS(TTM)-0.5367
P/E(FORWARD)-3.5841
P/B4.313
BVPS0.9390
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP24.11M
SHARES OUTSTANDING11.71M
NEXT EARNINGS--
FREE FLOAT5.95M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/19 13:47
Nasus Pharma Names Interim CFO as Longtime Finance Chief Resigns
Seeking Alpha·08/19 11:05
Nasus Pharma CFO Eyal Rubin to leave
NASDAQ·08/17 15:09
Nasus Pharma's H1 Loss Widens; Advances NS002 Toward Pivotal Study
Seeking Alpha·08/17 14:57
Nasus Pharma 1H non-GAAP EPS of -$0.54
TipRanks·08/17 13:22
Nasus Pharma Boosts Cash and Equity in First-Half 2026 Filing
Benzinga·08/17 12:15
Nasus Pharma H1 EPS $(0.54) Misses $(0.20) Estimate
TipRanks·07/28 11:35
Nasus Pharma appoints Brendan O’Grady as CEO
TipRanks·06/23 02:02
CEO’s Bold Move Sparks Fresh Optimism Around Nasus Pharma
TipRanks·06/09 20:27
Nasus Pharma Advances Intranasal Ondansetron After Positive Preclinical Data
Benzinga·04/22 17:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·04/10 21:13
12 Health Care Stocks Moving In Friday's After-Market Session
TipRanks·04/02 02:07
Nasus Pharma’s CEO Makes Bold Move With Fresh Insider Buy
Dow Jones·03/26 13:16
Nasus Pharma Price Target Cut to $18.00/Share From $19.00 by Citizens
Same Industry
Name/Symbol
Change%
Price